6 members of Congress have disclosed 14 trades in Dolby Laboratories, Inc. (DLB) since 2015: 8 purchases worth about $88.50K and 6 sales worth about $72.50K. The most active was Lisa C. McClain, with 4 trades. The latest trade was made on Sep 25, 2025.
DLB’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought DLB, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lisa C. McClainR-MI | 4 | 2 | 2 | $16.00K | $16.00K | $0.00 | -32.6% | Jun 24, 2025 | Sep 25, 2025 |
| 2 | Ada Norah HenriquezPR | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Apr 10, 2023 | Apr 10, 2023 |
| 3 | Donna E. ShalalaD-FL | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Jun 24, 2019 | Jun 24, 2019 |
| 4 | Lamar SmithR-TX | 2 | 2 | 0 | $16.00K | $0.00 | +$16.00K | -167.5% | Aug 8, 2018 | Sep 26, 2018 |
| 5 | James B. RenacciR-OH | 3 | 3 | 0 | $24.00K | $0.00 | +$24.00K | -188.6% | Dec 20, 2016 | Jul 12, 2017 |
| 6 | Thomas MacArthurR-NJ | 3 | 1 | 2 | $32.50K | $40.50K | -$8.00K | -196.8% | May 27, 2015 | Jan 19, 2016 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lisa C. McClainR-MI | DLBDolby Laboratories Common Stock | Spouse | Sell | $1K–$15K | Sep 25, 2025 | Oct 22, 2025 | 27d | -11.4% | -25.7% | |
| Lisa C. McClainR-MI | DLBDolby Laboratories Common Stock | Spouse | Buy | $1K–$15K | Sep 11, 2025 | Oct 22, 2025 | 41d | -12.2% | -26.6% | |
| Lisa C. McClainR-MI | DLBDolby Laboratories Common Stock | Spouse | Sell | $1K–$15K | Aug 4, 2025 | Sep 12, 2025 | 39d | -12.6% | -31.7% | |
| Lisa C. McClainR-MI | DLBDolby Laboratories Common Stock | Spouse | Buy | $1K–$15K | Jun 24, 2025 | Aug 13, 2025 | 50d late | -14.7% | -38.6% | |
| Ada Norah HenriquezPR | DLBDolby Laboratories Inc | Spouse | Sell | $1K–$15K | Apr 10, 2023 | May 2, 2023 | 22d | -25.0% | -108.7% | |
| Donna E. ShalalaD-FL | DLBDolby Laboratories | Self | Sell | $1K–$15K | Jun 24, 2019 | Apr 27, 2020 | 308d late | -2.4% | -158.6% | |
| Lamar SmithR-TX | DLBDolby Laboratories | Self | Buy | $1K–$15K | Sep 26, 2018 | Oct 9, 2018 | 13d | -8.7% | -168.1% | |
| Lamar SmithR-TX | DLBDolby Laboratories | Self | Buy | $1K–$15K | Aug 8, 2018 | Sep 7, 2018 | 30d | -3.3% | -166.8% | |
| James B. RenacciR-OH | DLBDOLBY LABORATORIES INCORPORATED | Self | Buy | $1K–$15K | Jul 12, 2017 | Jul 18, 2017 | 6d | +23.4% | -184.8% | |
| James B. RenacciR-OH | DLBDOLBY LABORATORIES INCORPORATED | Self | Buy | $1K–$15K | May 31, 2017 | Jun 7, 2017 | 7d | +25.6% | -185.9% | |
| James B. RenacciR-OH | DLBDOLBY LABORATORIES INCORPORATED | Self | Buy | $1K–$15K | Dec 20, 2016 | Jan 5, 2017 | 16d | +37.1% | -195.1% | |
| Thomas MacArthurR-NJ | DLBDolby Laboratories | Joint | Buy | $15K–$50K | Jan 19, 2016 | Feb 6, 2016 | 18d | +103.1% | -196.8% | |
| Thomas MacArthurR-NJ | DLBDolby Laboratories | Joint | Sell | $15K–$50K | Dec 16, 2015 | Jan 6, 2016 | 21d | +86.1% | -175.5% | |
| Thomas MacArthurR-NJ | DLBDolby Laboratories | Joint | Sell | $1K–$15K | May 27, 2015 | Jun 7, 2015 | 11d | +59.7% | -193.9% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
6 members of Congress have disclosed 14 trades in Dolby Laboratories, Inc. (DLB) since 2015: 8 purchases worth about $88.50K and 6 sales worth about $72.50K. The most active was Lisa C. McClain, with 4 trades. The latest trade was made on Sep 25, 2025. Most active: Lisa C. McClain (4), Ada Norah Henriquez (1), Donna E. Shalala (1), Lamar Smith (2), James B. Renacci (3).
Since 2015 they have disclosed 8 purchases and 6 sales; by the midpoints of the disclosed ranges, about $88.50K bought and $72.50K sold, a net purchase of $16.00K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded DLB on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.